探讨联合抗凝治疗在心源性脑梗塞中的应用效果  

To explore the effect of combined anticoagulant therapy on cardiogenic cerebral infarction

作　　者：熊建 Xiong Jian(Neurology Department,Nanchong Central Hospital,Nanchong,Sichuan 637000,China)

机构地区：[1]南充市中心医院神经内科,四川南充637000

出　　处：《医药前沿》2019年第5期18-19,共2页Journal of Frontiers of Medicine

摘　　要：目的:将联合抗凝治疗用于心源性脑梗塞中,对其应用效果进行研究.方法:对我院2016年5月-2017年7月期间收治的93例心源性脑梗塞患者分组研究,随机分成研究组(n=47)与参照组(n=46),参照组行常规治疗,研究组在此基础上联合抗凝治疗,比较两组治疗结果差异.结果:两组治疗前NIHSS评分、BI指数相比,差异不显著(P>0.05),研究组治疗后NIHSS评分与参照组相比,相对更低(P<0.05),B I指数与参照组相比,相对更高(P<0.05);研究组总有效率为89.36%,与参照组69.57%相比,相对更高(P<0.05);研究组并发症率为6.38%,与参照组19.57%相比,相对更低(P<0.05).结论:对心源性脑梗塞患者而言,实施联合抗凝治疗效果理想,可积极控制病情,促使患者神经功能尽快恢复,减少并发症,值得应用.Objective To study the effect of combined anticoagulant therapy in cardiogenic cerebral infarction. Methods 93 patients with cardiogenic cerebral infarction admitted in our hospital from May 2016 to July 2017 were randomly divided into two groups: the study group (n=47) and the reference group (n=46). The control group was treated with routine therapy;and the study group was treated with anticoagulant therapy. The results of treatment were compared between the two groups. Results There was no significant difference in NIHSS score and BI index between the two groups before treatment (P>0.05). The NIHSS score after treatment in the study group was lower than that in the control group (P<0.05) and the), BI index was higher than that in the control group (P<0.05). The total effective rate of the study group was 89.36%, which was higher than that of the control group was 69.57%(P<0.05), and the complication rate of the study group was 6.38%, which was lower than that of the control group was 19.57%(P<0.05). Conclusion For patients with cardiogenic cerebral infarction, the effect of combined anticoagulant therapy is ideal, it can actively control the condition, promote the recovery of neurological function and reduce complications, which is worthy of application.

关 键 词：联合抗凝 心源性脑梗塞 拜阿司匹林 低分子肝素 

分 类 号：R743[医药卫生—神经病学与精神病学]